CONTI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 66
EU - Europa 63
AS - Asia 46
OC - Oceania 2
AF - Africa 1
Totale 178
Nazione #
US - Stati Uniti d'America 66
CN - Cina 24
SG - Singapore 20
RU - Federazione Russa 19
DE - Germania 9
IE - Irlanda 9
IT - Italia 7
GB - Regno Unito 6
SE - Svezia 6
FR - Francia 5
AU - Australia 2
FI - Finlandia 2
ID - Indonesia 2
TG - Togo 1
Totale 178
Città #
Singapore 17
Chandler 10
Dublin 9
Ashburn 7
Beijing 4
Falkenstein 4
Falls Church 4
Sindelfingen 4
Jacksonville 3
Mestrino 3
Milan 3
Southend 3
Guangzhou 2
Helsinki 2
Houston 2
Jakarta 2
Kent 2
Lawrence 2
New York 2
Princeton 2
Seattle 2
Southport 2
Sydney 2
Tianjin 2
Wilmington 2
Zhengzhou 2
Brunswick 1
Chicago 1
Dallas 1
Dongguan 1
Essen 1
Fremont 1
Harbin 1
Lomé 1
Moscow 1
Nanjing 1
Putian 1
Redmond 1
Redwood City 1
San Secondo Parmense 1
Santa Clara 1
Shenyang 1
Swansea 1
Washington 1
Totale 117
Nome #
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 76
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis 36
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 29
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience 17
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 14
Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting 12
Totale 184
Categoria #
all - tutte 1.058
article - articoli 1.058
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 18 1 0 2 1 1 1 0 0 0 1 0
2021/20226 0 0 0 0 1 0 0 1 2 0 0 2
2022/202343 3 2 3 6 6 7 0 1 8 0 7 0
2023/202458 3 7 8 8 6 4 4 3 0 0 11 4
2024/202552 7 5 1 25 5 9 0 0 0 0 0 0
Totale 184